Sabra Health Care REIT (SBRA) surged 10.20% after announcing it will retenant 26 properties previously leased to Avamere, with new rent expected to increase nearly 30% to $53 million annually. The company also arranged a $300 million mortgage payoff from Recovery Centers of America for $200 million cash, using proceeds to reduce debt. These moves prompted Sabra to raise 2026 guidance for normalized AFFO to $1.59-$1.61 per share, though headline net income guidance decreased due to one-time costs.

Senior housing REITs Sabra Health Care and Welltower are bouncing back from pandemic lows, benefiting from strong demographic tailwinds and supply constraints. While Sabra offers a higher dividend yield of 6.14%, Welltower demonstrates superior financial performance with stronger growth metrics, lower debt levels, and a more profitable operating structure that captures operational upside. Welltower's total returns significantly outpace Sabra's over both short and long-term periods.

Engineers Gate Manager LP reduced its position in Sabra Health Care REIT by 1,513,777 shares (valued at ~$28.06 million), bringing the stake to 1.02% of the fund's assets. The sale reflects investor focus on healthcare REIT rental income sustainability, particularly as operators face challenges from Medicare/Medicaid reimbursement, labor costs, and occupancy trends.

Engineers Gate Manager LP increased its stake in Agree Realty (ADC) by 1,144,617 shares, bringing its total position to $85.16 million. The investment represents 1.01% of the fund's assets under management. ADC shares have appreciated 13.4% over the past year, outperforming the S&P 500.

Sabra Health Care REIT exceeded Q2 2025 analyst expectations with strong performance in managed senior housing, reporting normalized FFO of $0.37 per share and revenue of $189.15 million, representing a 7.4% year-over-year increase.

The headline numbers for Sabra (SBRA) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Evaluate the expected performance of Sabra (SBRA) for the quarter ended March 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.

On CNBC’s "Halftime Report Final Trades," Jim Lebenthal of Cerity Partners said if you are looking for a stock that’s on the verge of breaking out, Deere & Company (NYSE: DE). On March 25, Deere & Company said former Eastman Chemical Company executive, Kellye Walker, will join its leadership team as senior vice president, chief legal officer and worldwide public affairs, effective April 29. Stephen Weiss of Short Hills Capital Partners picked ASML Holding N.V. (NASDAQ: ASML), saying that ...

The headline numbers for Sabra (SBRA) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Sabra (SBRA) delivered FFO and revenue surprises of -2.94% and 0.05%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?

Beyond analysts' top -and-bottom-line estimates for Sabra (SBRA), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended December 2023.

National Health Investors reported strong Q4-2023 results, beating revenue and funds from operations estimates. Learn why NHI stock is a Hold.